1340
E. C. Constable et al.
(CB5), 125.6 (CA5), 120.0 (CA3), 109.5 (CB3). m/z (ESI-MS;
MeOH) 211.3 [M + Na]+ (base peak), 189.2 [M + H]+.
1,2-Bis(2,2ꢀ-bipyridin-6-yl)disulfide 4
[Cu(NCMe)4][PF6] (28.0 mg, 0.075 mmol) was added while the
mixture was stirred, causing an immediate colour change to dark
red-brown. The reaction mixture was heated at reflux for 1 h and
allowed to cool to room temperature. The solution was concen-
trated to one-third of its volume, and then Et2O was allowed to
diffuse into it over a period of 2 days. A red-orange precipitate
was collected by filtration. Attempts to isolate a pure sample of
Compound 3 (84.5 mg, 0.449 mmol) was dissolved in MeCN
(∼10 mL), and H2O2 (30%, 0.25 mL) was added dropwise. The
reaction mixture was stirred vigorously at room temperature for
2 h, and was then left in the refrigerator overnight. The colour-
less crystalline product 4 was separated by filtration (71.3 mg,
85%). Mp 123◦C. 1H NMR (500 MHz, CDCl3) δ/ppm 8.64
(br d, J ∼4.0, 1H, HA6), 8.34 (d, J 7.9, 1H, HA3), 8.20 (d, J
7.1, 1H, HB3), 7.72 (m, 2H, HA4+B4), 7.65 (d, J 7.9, 1H, HB5),
7.27 (m, 1H, HA5). 13C NMR (126 MHz, CDCl3) δ/ppm 158.6
(CB6), 156.4 (CB2), 155.4 (CA2), 149.4 (CA6), 138.4 (CA4/B4),
137.2 (CA4/B4), 124.3 (CA5), 121.6 (CA3), 120.0 (CB5), 118.5
(CB3). m/z (ESI-MS; MeOH) 397.3 [M + Na]+ (base peak),
375.3 [M + H]+. Anal. calc. for C20H14N4S2 (374.48) C 64.15,
H 3.77, N 14.96. Found: C 63.67, H 3.94, N 15.00%.
1
the product were unsuccessful. H NMR (400 MHz, CD3CN)
δ/ppm 8.50 (br, 1H), 8.28 (br, 1H), 8.16 (br, 1H), 8.02 (br, 1H),
7.81 (br, 1H), 7.60–7.54 (br, overlapping, 2H). After several
months, green crystals of [Cu(5)2]·2.5MeCN had formed in the
NMR tube.
[Cu2(μ-4)(μ-6)][ClO4]4
Compounds
4 (9.2 mg, 0.0245 mmol) and 6 (13.0 mg,
0.0245 mmol) were suspended in MeCN (2 mL) and Cu(ClO4)2·
6H2O was added (18.2 mg, 0.0491 mmol). The reaction mix-
ture was sealed in a vial and heated in a microwave reactor at
120◦C for 10 min, then allowed to cool to room temperature.
The solid product was separated by filtration. A sample of the
crude product was dissolved in MeNO2 with a drop of MeOH
added, and Et2O was allowed to diffuse into the solution. Crys-
tals of [Cu2(μ-4)(μ-6)][ClO4]4·2MeNO2·MeOH·3H2O formed
overnight. m/z (ESI MS; MeCN) 1327.0 [Cu2(4)(6)(ClO4)3]+,
1066.2 [Cu(4)(6)(ClO4)]+, 690.1 [Cu(6)(ClO4)]+ (base peak),
536.0 [Cu(4)(ClO4)]+ (see text).
[Zn(2)2][ClO4]2
Compound 2 (26.5 mg, 0.0658 mmol) was suspended in MeCN
(10 mL) and Zn(ClO4)2·6H2O (24.5 mg, 0.0658 mmol) was
added while the colourless reaction mixture was stirred. After
being heated at reflux for 1 h, the reaction mixture was allowed
to cool to room temperature. It was concentrated to ∼one-third
of the volume and then Et2O was diffused into the solution
overnight. The colourless precipitate was separated by filtra-
tion and dried under high vacuum to yield [Zn(2)2][ClO4]2 as
an off-white microcrystalline solid (33.8 mg, 77.0%). 1H NMR
(500 MHz, CD3CN) δ/ppm 8.61 (d, J 8.1, 1H, HB3), 8.47 (d,
J 8.0, 1H, HA3), 8.37 (t, J 7.9, 1H, HB4), 8.29 (t, J 7.9, 1H,
Crystal Structure Determinations
Data were collected on Bruker-Nonius Kappa charge coupled
device or Stoe IPDS diffractometers; data reduction, solution
and refinement used the programs COLLECT,[30] SIR92,[31]
DENZO/SCALEPACK,[32] and CRYSTALS,[33] or Stoe IPDS
software[34] and SHELXL97.[35] Hydrogen atoms bonded to N or
Ohavebeenlocated, optimized, andthenincludedasfixedcontri-
butions. ORTEP figures were drawn with the program ORTEP-
3 for Windows.[36] Structures were analyzed using Mercury
v. 2.3.[37,38]
H
A4), 8.12 (d, J 7.8, 1H, HB5), 7.67 (d, J 7.8, 1H, HA5), 1.99 (s,
3H, HMe). 13C NMR (126 MHz, CD3CN) δ/ppm 160.4 (CA6),
158.9 (CB6), 153.5 (CB2), 148.6 (CA2), 144.5 (CB4), 143.6
(CA4), 132.2 (CB5), 130.7 (CA5), 124.4 (CB3), 122.8 (CA3),
24.1 (CMe). m/z (MALDI MS) 466.53 [Zn(2)]+. Anal. calc. for
C22H18Cl2N4O8S2Zn (666.85) C 39.63, H 2.72, N 8.40. Found
C 39.64, H 2.88, N 8.67%.
3: C10H8N2S, M 188.25, colourless plate, triclinic, space
group P−1, a 7.9706(1), b 9.5618(2), c 12.1532(2) Å, α
77.4044(9), β 76.2747(9), γ 87.3699(10)◦, U 878.11(3) Å3, Z 4,
D 1.424 Mg m−3, μ(MoKα) 0.315 mm−1, F(000) 392, T 173 K,
10187 reflections, 5146 unique (Rint 0.025), R1 0.0358 (3131
reflections, 235 parameters, I > 3.0σ(I)), wR2 0.0458, R1 0.0647
(all data), wR2 0.0564 (all data), goodness of fit (GOF) 1.0221.
4: C20H14N4S2, M 374.49, colourless block, monoclinic,
space group C2/c, a 19.253(4), b 7.9777(16), c 11.636(2) Å, β
105.62(3)◦, U 1721.2(6) Å3, Z 4, D 1.445 Mg m−3, μ(MoKα)
0.321 mm−1, F(000) 776, T 173 K, 21632 reflections, 3124
unique (Rint 0.0364), R1 0.0385 (3009 reflections, 118 parame-
ters, I > 2.0σ(I)), wR2 0.1067, R1 0.0400 (all data), wR2 0.1078
(all data), GOF 1.101.
[Zn(4)2][ClO4]2
Compound 4 (21.9 mg, 0.0585 mmol) was suspended in MeCN
(10 mL) and Zn(ClO4)2·6H2O (21.8 mg, 0.0585 mmol) was
added to the stirring mixture. After being heated at reflux for
1 h, the reaction mixture was allowed to cool to room tem-
perature, and was concentrated to ∼one-third of its volume.
Slow diffusion of Et2O into the solution overnight yielded a
colourless precipitate, which was separated by filtration and
dried under high vacuum. [Zn(4)2][ClO4]2 was isolated as an
off-white microcrystalline solid (31.6 mg, 84.6%). 1H NMR
(500 MHz, CD3CN) δ/ppm 8.57 (m, 2H, HA3+B3), 8.41 (t,
J 7.8, 1H, HA4), 8.37 (d, J 4.9, 1H, HA6), 8.32 (t, J 7.9, 1H,
H
B4), 8.06 (d, J 7.8, 1H, HB5), 7.85 (m, 1H, HA5). 13C NMR
2{[Zn(2)(OClO3)][ClO4]}·EtOH: C46H42Cl4N8O17S4Zn2,
M 1379.72, colourless plate, monoclinic, space group C2/c, a
28.5683(12), b 10.4110(5), c 22.0368(10) Å, β 125.360(2)◦, U
(126 MHz, CD3CN) δ/ppm 159.0 (CB6), 153.0 (CB2), 149.8
(CA6), 149.3 (CA2), 144.2 (CB4), 143.8 (CA4), 131.3 (CB5),
129.2 (CA5), 124.7 (CA3/B3), 124.1 (CA3/B3). m/z (MALDI
MS)538.57[Zn(4)ClO4]+.Anal. calc. forC20H14Cl2N4O8S2Zn
(638.79) C 37.61, H 2.21, N 8.77. Found C 37.58, H 2.27,
N 8.90%.
5345.3(4) Å3, Z 4, D 1.714 Mg m−3, μ(MoKα) 1.334 mm−1
,
F(000) 2808, T 173 K, 33248 reflections, 5209 unique
(Rint 0.066), R1 0.0728 (3791 reflections, 377 parameters,
I > 1.0σ(I)), wR2 0.0798, R1 0.1000 (all data), wR2 0.1029 (all
data), GOF 1.1410.
[Zn(4)(OClO3)][ClO4]: C20H14Cl2N4O8S2Zn, M 638.77,
colourless block, monoclinic, space group P21/c, a 15.2359(8),
b 16.2519(9), c 19.4989(11) Å, β 109.732(3)◦, U 4544.7(4) Å3,
[Cu(5)2]·2.5MeCN
Compound 4 (28.1 mg, 0.075 mmol) was suspended in
MeCN and the mixture degassed with N2 for 15 min.